WHOOP has secured $575 million in a Series G funding round, valuing the health wearable company at $10.1 billion, nearly triple its 2021 valuation. The Boston-based startup, known for its screen-free tracker, is backed by prominent investors including sovereign wealth funds and celebrity athletes, setting the stage for an IPO. Founder and CEO Will Ahmed indicated this would be their last private funding round.
WHOOP’s Series G round, closed on March 31, 2026, demonstrates significant growth since its last valuation of $3.6 billion in 2021. Ahmed expressed intentions of transitioning towards a public listing.
The funding was led by Collaborative Fund, with participation from major investors like Mubadala Investment Company, Qatar Investment Authority, Abbott, Mayo Clinic, and a range of other notable funds and individuals including Cristiano Ronaldo and LeBron James. This diverse investor base reflects WHOOP’s strategic shift from fitness gadgetry to a comprehensive health platform.
Ahmed emphasized the significance of integrating sophisticated investors and global athletes in supporting WHOOP’s mission to enhance human performance and healthspan.
Founded in 2012 at Harvard, WHOOP distinguishes itself by its lack of a screen and conventional activity trackers. Its focus remains on measuring strain, recovery, and sleep through user data in its app, which advises on lifestyle impacts. WHOOP’s membership has grown to over 2.5 million, with a bookings run rate of $1.1 billion by the end of 2025.
WHOOP experienced significant growth in female membership, leading to tailored product and marketing strategies.
WHOOP introduced its first medical-grade device, WHOOP MG, in May 2025, featuring advanced health monitoring capabilities. Its Advanced Labs service, offering a comprehensive biomarker panel, launched to a large waitlist and combines blood testing with wearable data for detailed health insights.
In March 2026, WHOOP announced an expansion fueled by AI and talent acquisition, planning to significantly increase their global team. The Series G funds will support U.S. growth and international expansion, aiming to evolve as a critical component of health technology.
With the IPO in sight, WHOOP is working towards establishing itself as a notable public company. The company’s positioning as an integral health data platform aims to challenge existing market perceptions, supported by its rich data history and strategic partnerships.
WHOOP’s future as a public entity hinges on its ability to convince investors of its platform’s potential in preventive medicine, leveraging its data-driven, member-focused approach.